Release Date: 01/11/19 09:35 Summary: CSR Limited Review of Results - half year end 30 Sept 2019 Price Sensitive: Yes Download Document 743.36KB Download
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution